Significant differences between patients with TB and healthy controls were observed in the following clinical indices (P < 0.05, Table 3): plasma prothrombin time (PT), international normalized ratio (INR), plasma fibrinogen (FIB), activated partial thromboplastin time (APTT), thromboplastin time (TT), total cholesterol, high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C). The gene discussed is F2; the disease is tuberculosis.